After taking a pill, the drugs it contains are distributed throughout the human body, reaching the tissues and cells affected by diseases and performing their intended function. However, they also enter healthy cells, where they often cause more harm than good. In a study published in the journal “Nature Communications”, a multidisciplinary team led by PROXIDRUGS project lead Felix Hausch and Alexander Loewer from TU Darmstadt has now shown how proteins occurring naturally in human cells can...

Recent changes at Genentech have brought a wider debate into sharp focus. As the company makes AI increasingly central to its research strategy, several internationally renowned scientists have been let go as part of a broader restructuring and shift in priorities. In a new Comment in Nature Cell Biology, PROXIDRUGS Speaker Ivan Đikić from Goethe University Frankfurt and Henning Walczak from UCL Cancer Institute and University of Cologne ask what such changes could mean for the future of...

On 10 September PROXIDRUGS had the pleasure of bringing together early-career researchers for an inspiring start-up event at FUTURY in Frankfurt. Under the title “From Scientific Innovation to Entrepreneurship: A Goethe University Start-up Story”, PROXIDRUGS member Manuel Kaulich shared his perspective as a scientist and founder, offering open and valuable insights into what it means to translate a scientific idea into a company. Manuel described himself as “pathologically enthusiastic...